Prof. Richard Knox BSc, PhD
Research and Development
A member of the management team, Richard has particular responsibility for initiation and coordination of the company’s research programmes and will also manage biochemical research. Professor Richard Knox was the leader of the Molecular Pharmacology team in the CRC Centre for Cancer Therapeutics at the Institute of Cancer Research (ICR), London.
Mrs Judith Phillips ACIS
Company Secretary & Financial Controller
Qualified as an Associate of the Chartered Institute of Secretaries in 2002, she assisted with the start-up and was a founder shareholder of Kymed which subsequently merged with Enzacta to form Enact Pharma plc.